Unnamed: 0,title,date,stock,sentiment
212439.0,CASI Pharmaceuticals Submits a Clinical Trial Application in the UK for a Phase 1 Study of its Anti-38 Monoclonal,2020-06-08 07:03:00-04:00,CASI,neutral
212440.0,70 Biggest Movers From Yesterday,2020-05-21 05:22:00-04:00,CASI,neutral
212441.0,52 Stocks Moving In Wednesday's Mid-Day Session,2020-05-20 13:17:00-04:00,CASI,neutral
212442.0,"CASI Pharmaceuticals Q1 EPS $(0.090), Same YoY",2020-05-11 07:12:00-04:00,CASI,neutral
212443.0,"HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $3.5",2020-03-24 12:08:00-04:00,CASI,negative
212444.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,CASI,negative
212445.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,CASI,negative
212446.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-11 11:41:00-04:00,CASI,negative
212447.0,20 Healthcare Stocks Moving In Monday's Session,2020-03-09 13:40:00-04:00,CASI,neutral
212448.0,"The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19",2020-03-05 08:05:00-05:00,CASI,negative
212449.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-04 11:12:00-05:00,CASI,negative
212450.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,CASI,negative
212451.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,CASI,neutral
212452.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,CASI,negative
212453.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,CASI,negative
212454.0,"Casi Pharmaceuticals Says Company's CFO George Chi's Employment Will Cease Effective February 21, 2020",2020-02-20 16:50:00-05:00,CASI,positive
212455.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-20 10:54:00-05:00,CASI,negative
212456.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,CASI,negative
212457.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,CASI,negative
212458.0,Stocks That Hit 52-Week Lows On Wednesday,2020-02-12 11:50:00-05:00,CASI,negative
212459.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,CASI,positive
212460.0,Stocks That Hit 52-Week Lows On Monday,2020-02-10 10:28:00-05:00,CASI,negative
212461.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,CASI,neutral
212462.0,Stocks That Hit 52-Week Lows On Tuesday,2020-02-04 11:05:00-05:00,CASI,negative
212463.0,"The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares",2020-02-04 07:51:00-05:00,CASI,negative
212464.0,Stocks That Hit 52-Week Lows On Monday,2020-02-03 11:53:00-05:00,CASI,negative
212465.0,23 Biotechnology Stocks Moving In Monday's After-Market Session,2020-01-27 23:45:00-05:00,CASI,neutral
212466.0,36 Healthcare Stocks Moving In Monday's After-Market Session,2020-01-27 23:41:00-05:00,CASI,neutral
212467.0,"CASI Pharmaceuticals Q3 EPS $(0.1), Same YoY",2019-11-12 07:09:00-05:00,CASI,neutral
212468.0,CASI Pharmaceuticals Enters Exclusive Distribution Agreement With Pharmathen Global BV For The Development And Distribution Of Octreotide Long Acting Injectable Microsphere In China.,2019-11-07 07:43:00-05:00,CASI,positive
212469.0,"CASI Pharma 8-K Shows Co. Entered Exclusive License Distribution License Deal With Pharmathen To Develop, Distribute Octreotide Long-Acting Injectable Microsphere In China",2019-11-01 16:58:00-04:00,CASI,positive
212470.0,CASI Pharma Reports China's National Medical Product Administration Accepted Trial Application For Co.'s CD19 CAR-T Product,2019-09-16 06:09:00-04:00,CASI,positive
212471.0,Ligand Pharma Reports Partnership With CASI Pharma To Launch EVOMELA in China,2019-08-12 09:00:00-04:00,CASI,neutral
212472.0,CASI Pharma Reports Launch Of EVOMELA In China,2019-08-12 07:09:00-04:00,CASI,neutral
212473.0,CASI Pharmaceuticals Q2 EPS $(0.16) Down From $(0.07) YoY,2019-08-09 07:14:00-04:00,CASI,neutral
212474.0,Shares of several companies in the biotech space are trading higher after Pfizer announced it will acquire Array BioPharma.,2019-06-17 10:10:00-04:00,CASI,positive
212475.0,"CASI Pharma Acquires Worldwide Rights to Commercialize Anti-CD19 T-Cell Therapy From Juventas Cell Therapy, CASI to Invest RMB 80M in Juventas",2019-06-17 07:02:00-04:00,CASI,neutral
212476.0,"CASI Pharmaceuticals Q1 EPS $(0.09), Inline",2019-05-15 07:46:00-04:00,CASI,neutral
212477.0,This Day In Market History: New York Times Article Suggests Cancer Cure By Year 2000,2019-05-03 07:34:00-04:00,CASI,negative
212478.0,CASI Pharmaceuticals Obtains Global Rights To TSK011010 Anti-CD38 Monoclonal Antibody From Black Belt Therapeutics For €5M And An Equity Investment Of €2M,2019-04-17 07:03:00-04:00,CASI,neutral
212479.0,50 Biggest Movers From Yesterday,2019-04-09 06:48:00-04:00,CASI,neutral
212480.0,48 Stocks Moving In Monday's Mid-Day Session,2019-04-08 12:48:00-04:00,CASI,neutral
212481.0,"CASI Pharmaceuticals, Inc. - Common Stock Q4 EPS $(0.10) Down From $(0.08) YoY",2019-03-29 07:03:00-04:00,CASI,neutral
212482.0,CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection In China,2019-03-13 07:15:00-04:00,CASI,positive
212483.0,CASI Pharma Reports China National Medical Products Administration Approved CTA To Conduct Registration Trial For MARQIBO,2019-03-07 07:09:00-05:00,CASI,positive
212484.0,CASI Pharmaceuticals Announces China National Medical Products Administration Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN,2019-02-19 07:14:00-05:00,CASI,positive
212485.0,22 Stocks Moving In Monday's Pre-Market Session,2018-12-31 08:03:00-05:00,CASI,neutral
212486.0,52 Biggest Movers From Yesterday,2018-12-13 04:54:00-05:00,CASI,neutral
212487.0,41 Stocks Moving In Wednesday's Mid-Day Session,2018-12-12 12:33:00-05:00,CASI,neutral
212488.0,56 Biggest Movers From Yesterday,2018-12-04 05:02:00-05:00,CASI,neutral
212489.0,46 Stocks Moving In Monday's Mid-Day Session,2018-12-03 12:37:00-05:00,CASI,neutral
212490.0,CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection,2018-12-03 08:14:00-05:00,CASI,positive
212491.0,52 Biggest Movers From Friday,2018-12-03 05:42:00-05:00,CASI,neutral
212492.0,38 Stocks Moving In Friday's Mid-Day Session,2018-11-30 12:33:00-05:00,CASI,neutral
212493.0,55 Biggest Movers From Friday,2018-11-19 05:53:00-05:00,CASI,neutral
212494.0,"CASI Pharma Announces Will Build A GMP Manufacturing Site In Wuxi, China",2018-11-16 07:05:00-05:00,CASI,neutral
212495.0,CASI Pharma Filing Shows Registration For ~9.1M Share Common Stock Offering Via Selling Shareholders,2018-11-14 16:46:00-05:00,CASI,positive
212496.0,CASI Pharmaceuticals Q3 EPS $(0.10) Down From $(0.03) YoY,2018-11-14 07:02:00-05:00,CASI,neutral
212497.0,64 Biggest Movers From Yesterday,2018-10-31 05:00:00-04:00,CASI,neutral
212498.0,48 Biggest Movers From Yesterday,2018-10-30 04:42:00-04:00,CASI,neutral
212499.0,56 Biggest Movers From Yesterday,2018-10-25 05:29:00-04:00,CASI,neutral
212500.0,56 Biggest Movers From Yesterday,2018-10-24 05:53:00-04:00,CASI,neutral
212501.0,"CASI Pharma Reports Purchase Of HBV ANDA From Laurus Labs, No Terms Disclosed",2018-10-23 07:08:00-04:00,CASI,negative
212502.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-10-04 07:58:00-04:00,CASI,neutral
212503.0,CASI Pharmaceuticals Appoints Larry Zhang To President,2018-10-02 07:07:00-04:00,CASI,neutral
212504.0,CASI Pharma Names George Chi CFO,2018-09-28 07:07:00-04:00,CASI,neutral
212505.0,"CASI Pharmaceuticals Announces $48.5M Private Placement, Will Issue 9.048M Shares At Price Of $5.36/Share",2018-09-14 07:01:00-04:00,CASI,positive
212506.0,45 Stocks Moving In Tuesday's Mid-Day Session,2018-08-14 12:34:00-04:00,CASI,neutral
212507.0,CASI Pharmaceuticals Q2 EPS $(0.12) Misses $(0.07) Estimate,2018-08-14 07:03:00-04:00,CASI,negative
212508.0,CASI Pharma S-3 Shows Registration For Offering Of ~17.28M Shares Of Common Stock Via Selling Holders,2018-07-17 16:39:00-04:00,CASI,positive
212509.0,"Benzinga's Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index",2018-07-05 07:43:00-04:00,CASI,neutral
212510.0,"CASI Pharma Added To Russell 2000, 3000 And Microcap Indices",2018-07-03 13:05:00-04:00,CASI,neutral
212511.0,44 Biggest Movers From Friday,2018-07-02 04:48:00-04:00,CASI,neutral
212512.0,"CASI Pharma Shares Fall ~7% Over Last Min., Not Seeing News To Justify Dip Lower; Shares Had Been Up ~10% For Session On No News",2018-06-26 13:10:00-04:00,CASI,neutral
212513.0,25 Stocks Moving In Monday's Pre-Market Session,2018-06-25 08:27:00-04:00,CASI,neutral
212514.0,44 Stocks Moving In Thursday's Mid-Day Session,2018-06-21 13:50:00-04:00,CASI,neutral
212515.0,Mid-Day Market Update: Dow Down Over 150 Points; CASI Pharmaceuticals Shares Spike Higher,2018-06-21 12:22:00-04:00,CASI,positive
212516.0,Mid-Morning Market Update: Markets Open Lower; Kroger Earnings Beat Expectations,2018-06-21 10:11:00-04:00,CASI,negative
212517.0,Benzinga Pro's 5 Stocks To Watch Today,2018-06-21 08:54:00-04:00,CASI,neutral
212518.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-06-21 08:03:00-04:00,CASI,neutral
212519.0,CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol,2018-06-21 07:02:00-04:00,CASI,positive
212520.0,42 Biggest Movers From Yesterday,2018-06-13 05:31:00-04:00,CASI,neutral
212521.0,CASI Pharmaceuticals Q1 EPS $(0.05) Misses $(0.01) Estimate,2018-05-15 07:07:00-04:00,CASI,negative
212522.0,"Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss",2018-05-03 08:31:00-04:00,CASI,negative
212523.0,25 Stocks Moving In Tuesday's Mid-Day Session,2018-04-10 12:40:00-04:00,CASI,neutral
212524.0,30 Biggest Movers From Friday,2018-04-09 04:23:00-04:00,CASI,neutral
212525.0,"CASI Pharma Shares Up 22%, Rebounding From Yesterday's Weakness After Announcing Thursday That Chinese Regulators Agreed To Review Its EVOMELA Cancer Treatment",2018-04-06 12:48:00-04:00,CASI,negative
212526.0,28 Stocks Moving In Thursday's Mid-Day Session,2018-04-05 12:58:00-04:00,CASI,neutral
212527.0,22 Stocks Moving In Thursday's Pre-Market Session,2018-04-05 08:12:00-04:00,CASI,neutral
212528.0,UPDATE: CASI Says CDE AdComm Will Review EVOMELA Apr. 25-26,2018-04-05 08:05:00-04:00,CASI,neutral
212529.0,CASI Pharma Offers Update On EVOMELA: Says Received Advisory Meeting Notice From China Center For Drug Evaluation,2018-04-05 08:05:00-04:00,CASI,neutral
212530.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-04-04 12:50:00-04:00,CASI,neutral
212531.0,18 Stocks Moving In Wednesday's Pre-Market Session,2018-04-04 08:19:00-04:00,CASI,neutral
212532.0,35 Biggest Movers From Yesterday,2018-04-04 04:20:00-04:00,CASI,neutral
212533.0,33 Stocks Moving In Monday's Mid-Day Session,2018-04-02 12:53:00-04:00,CASI,neutral
212534.0,Mid-Day Market Update: NASDAQ Down Over 2%; SELLAS Life Sciences Shares Spike Higher,2018-04-02 12:05:00-04:00,CASI,positive
212535.0,CASI Pharma Q4 EPS $(0.08) Misses $(0.02) Est.,2018-03-29 07:01:00-04:00,CASI,negative
212536.0,33 Biggest Movers From Yesterday,2018-03-21 05:30:00-04:00,CASI,neutral
212537.0,28 Stocks Moving In Tuesday's Mid-Day Session,2018-03-20 13:46:00-04:00,CASI,neutral
212538.0,UPDATE: CASI Pharmaceuticals Will Issue 15.43M Shares Of Stock With Accompanying Warrants To Purchase 6.17M Shares Of Stock At Purchase Price Of $3.24; Warrants Will Become Exercisable 180 Days After Issuance At $3.69/Share Exercise Price,2018-03-20 09:31:00-04:00,CASI,positive
212539.0,CASI Pharma Reports $50M Private Placement To Prepare Co. For Commercialization In China,2018-03-20 09:29:00-04:00,CASI,neutral
212540.0,CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc.,2018-01-26 17:11:00-05:00,CASI,neutral
212541.0,CASI Pharma S-3 Shows Registration For $100M Mixed Securities Shelf Offering,2017-12-13 18:14:00-05:00,CASI,positive
212542.0,Mid-Morning Market Update: Markets Open Higher; VeriFone Issues Weak Outlook,2017-12-13 10:10:00-05:00,CASI,negative
212543.0,40 Biggest Movers From Yesterday,2017-12-13 05:08:00-05:00,CASI,neutral
212544.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-12-07 08:02:00-05:00,CASI,neutral
212545.0,42 Biggest Movers From Yesterday,2017-12-07 05:14:00-05:00,CASI,neutral
212546.0,30 Stocks Moving In Wednesday's Mid-Day Session,2017-12-06 12:27:00-05:00,CASI,neutral
212547.0,32 Biggest Movers From Friday,2017-12-04 05:37:00-05:00,CASI,neutral
212548.0,40 Biggest Movers From Wednesday,2017-11-24 05:50:00-05:00,CASI,neutral
212549.0,"CASI Pharma Reports Q3 EPS $(0.03) From $(0.03) YoY, No Sales",2017-11-14 07:07:00-05:00,CASI,negative
212550.0,CASI Pharma Announces $23.8M Direct Offering By Selling Shareholders,2017-10-13 10:01:00-04:00,CASI,neutral
212551.0,33 Stocks Moving In Thursday's Mid-Day Session,2017-10-12 12:40:00-04:00,CASI,neutral
212552.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-10-12 08:03:00-04:00,CASI,neutral
212553.0,"CASI Pharmaceuticals Director He Wei-Wu Buys 100,000 @ Avg Price: $1.95 -Form4",2017-10-11 17:04:00-04:00,CASI,neutral
212554.0,Mid-Afternoon Market Update: Hudson Technologies Drops Amid Concerning Guidance; Aerie Pharmaceutical Shares Gain,2017-10-11 14:29:00-04:00,CASI,positive
212555.0,28 Stocks Moving In Wednesday's Mid-Day Session,2017-10-11 12:19:00-04:00,CASI,neutral
212556.0,Mid-Day Market Update: VOXX International Falls After Q2 Results; CASI Pharmaceuticals Shares Climb,2017-10-11 12:09:00-04:00,CASI,positive
212557.0,Mid-Morning Market Update: Markets Mostly Flat; Delta Air Lines Earnings Top Views,2017-10-11 10:12:00-04:00,CASI,positive
212558.0,CASI Pharmaceuticals Shares Rise 97% After Filing Shows Insider Buy of 200K Shares on Tuesday,2017-10-11 09:41:00-04:00,CASI,positive
212559.0,Casi Pharmaceutical Shares Spike to $4.28 on Volume,2017-10-11 09:39:00-04:00,CASI,positive
212560.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-10-11 08:22:00-04:00,CASI,neutral
212561.0,12 Stocks Moving In Tuesday's After-Hours Session,2017-10-10 18:24:00-04:00,CASI,neutral
212562.0,"CASI Pharma Shares Continue Higher After Hours, Up 17%, Following 15% Afternoon Rally Tues.; Form 4 Filing From Director He Wei-Wu Shows Purchase Of 200K Shares On Oct. 5, 6",2017-10-10 17:56:00-04:00,CASI,positive
212563.0,"CASI Pharma Offers Pipeline Development Updates, For EVOMELA, MARQIBO, ZEVALIN, ENMD-2076",2017-09-07 07:13:00-04:00,CASI,neutral
212564.0,"CASI Pharma Q2 EPS $(0.04) from $(0.08) YoY, No Sales",2017-08-14 07:08:00-04:00,CASI,negative
212565.0,"CASI Pharma Q1 EPS $(0.03), No Sales",2017-05-15 07:05:00-04:00,CASI,negative
212566.0,"Casi Pharmaceuticals Announces Decision to Stop Further Patient Enrollment in Phase 2, Open-label Study of ENMD-2076 in TNBC; Study Continues",2017-04-14 08:11:00-04:00,CASI,negative
212567.0,CASI Pharma Reports Q4 EPS $(0.05) vs $(0.07) Est.,2017-03-31 07:06:00-04:00,CASI,neutral
212568.0,CASI Pharmaceuticals' Import Drug Registration Application For EVOMELA Accepted For Review By CFDA,2016-12-05 07:02:00-05:00,CASI,positive
212569.0,"CASI Pharma Q3 EPS $(0.08) vs $(0.03) Est, No Revenue",2016-11-14 07:08:00-05:00,CASI,negative
212570.0,15 Stocks That Rallied For Three Days On No News,2016-10-13 07:05:00-04:00,CASI,negative
212571.0,18 Stocks That Rallied For Three Days On No News,2016-10-12 10:13:00-04:00,CASI,negative
212572.0,Benzinga's Top Initiations,2016-09-22 09:49:00-04:00,CASI,positive
212573.0,Maxim Group Initiates Coverage on CASI Pharmaceuticals at Buy,2016-09-22 07:17:00-04:00,CASI,neutral
212574.0,12 Biggest Mid-Day Gainers For Tuesday,2016-08-16 12:38:00-04:00,CASI,neutral
212575.0,CASI Pharma Says Phase 2 Trial of ENMD-2076 Has met Stage 1 Endpoint,2016-08-16 07:11:00-04:00,CASI,neutral
212576.0,CASI Pharmaceuticals Reports Q2 EPS $(0.08) vs. Est. $(0.04),2016-08-15 07:04:00-04:00,CASI,neutral
212577.0,"UPDATE: Sparkle Byte to Acquire Remaining 4,340,741 Shares of CASI Common Stock and Warrants to Acquire 868,148 Shares of Common Stock",2016-06-30 06:07:00-04:00,CASI,positive
212578.0,Sparkle Byte Reports 20.7% Stake in CASI Pharmaceuticals in Amended 13D,2016-06-30 06:05:00-04:00,CASI,positive
212579.0,CASI Pharma Reports Q1 EPS $(0.04) vs $(0.05) Est.,2016-05-13 07:04:00-04:00,CASI,neutral
212580.0,CASI Pharma Reports Received CFDA Approval for Conducting of Phase 2 Trial with ENMD-2076 for FLC,2016-05-12 07:07:00-04:00,CASI,positive
212581.0,CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase 2 Clinical Trial With ENMD-2076 For Fibrolamellar Carcinoma,2016-05-12 07:03:00-04:00,CASI,positive
212582.0,CASI Pharmaceuticals Regained Compliance with Nasdaq Minimum Bid Price Requirement,2016-03-31 08:03:00-04:00,CASI,neutral
212583.0,"CASI Pharma Q4 EPS ($0.05) vs ($0.03) est, Revenue $0 vs $50K est",2016-03-28 07:05:00-04:00,CASI,neutral
212584.0,CASI Pharmaceuticals Reports Q4 EPS $(0.05) vs. Est. $(0.03),2016-03-28 07:02:00-04:00,CASI,neutral
212585.0,Sparkle Byte Shows 13.6% Stake in Casi Pharma,2016-01-25 06:09:00-05:00,CASI,positive
212586.0,"CEO Ren Buys 15,000 Shares of CASI Pharmaceuticals @$0.73/Share -Form 4",2016-01-21 14:46:00-05:00,CASI,positive
212587.0,CASI Pharma. Reports Closing Of Strategic Financing With Receipt Of $10.3M In Proceeds,2016-01-19 08:32:00-05:00,CASI,neutral
212588.0,CASI Pharmaceuticals' Import Drug Registration Application for MARQIBO Accepted For Review By China's FDA,2016-01-12 07:07:00-05:00,CASI,positive
212589.0,CASI Pharmaceuticals Reports Q3 EPS ($0.05) vs. Est. ($0.07),2015-11-13 07:03:00-05:00,CASI,neutral
212590.0,Casi Announces Data On Anti-Tumor Activity Of ENMD-2076 In Triple Negative Breast Cancer Animal Models Presented In Poster Session at AACR-NCI-EORTC Conference,2015-11-08 17:40:00-05:00,CASI,negative
212591.0,CASI Pharmaceuticals Reports First Patient Dosed In Phase 2 Trial For ENMD-2076 In Fibrolamellar Carcinoma,2015-11-04 07:05:00-05:00,CASI,neutral
212592.0,"H.C. Wainwright Assumes CASI Pharmaceuticals at Buy, Announces $3.00 PT",2015-10-29 07:50:00-04:00,CASI,neutral
212593.0,Morning Market Gainers,2015-10-14 09:42:00-04:00,CASI,neutral
212594.0,CASI Pharmaceuticals Receives EU Orphan Drug Designation For The Use Of ENMD-2076 To Treat Hepatocellular Carcinoma Including Fibrolamellar Carcinoma,2015-10-14 07:01:00-04:00,CASI,positive
212595.0,S-3 from CASI Pharma Shows Registration for $30M Mixed Securities Shelf Offering,2015-10-06 16:34:00-04:00,CASI,positive
212596.0,"CASI Pharma Announces Will Raise $25.1M in Private Placement of Stock, Warrants",2015-09-21 07:04:00-04:00,CASI,neutral
212597.0,CASI Pharmaceuticals Reports Q2 EPS $(0.06) vs. Prior Year Quarter Inline,2015-08-14 07:02:00-04:00,CASI,neutral
212598.0,CASI Pharmaceuticals Announces Availabilty Of Anti-Cancer Drug ZEVALIN® In Hong Kong For Non-Hodgkin's Lymphoma,2015-07-20 07:09:00-04:00,CASI,neutral
212599.0,Morning Market Gainers,2015-06-23 09:42:00-04:00,CASI,neutral
212600.0,"Time To Buy Casi Pharma, HC Wainwright",2015-06-23 08:12:00-04:00,CASI,neutral
212601.0,"H.C. Wainwright Initiates Coverage on CASI Pharmaceuticals at Buy, Announces $2.50 PT",2015-06-23 07:21:00-04:00,CASI,neutral
212602.0,CASI Files New Drug Clinical Trial Application With Chinese FDA To Expand U.S. Development Of ENMD-2076 In Fibrolamellar Carcinoma,2015-06-04 07:02:00-04:00,CASI,positive
212603.0,"CASI Pharma Reports Q1 Loss $0.06, no estimates",2015-05-15 07:00:00-04:00,CASI,negative
212604.0,CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma,2015-03-30 07:04:00-04:00,CASI,positive
212605.0,CASI Pharma Recieves CFDA Approval  For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma,2015-03-30 07:02:00-04:00,CASI,positive
212606.0,Casi Pharma Announces Approval From CFDA for Phase 2 Trial,2015-03-30 07:00:00-04:00,CASI,positive
212607.0,"CASI Pharma Reports Q4  EPS (0.05), Rev. $23.7M",2015-03-27 07:01:00-04:00,CASI,neutral
212608.0,CASI Pharmaceuticals Initiates  Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China,2015-03-25 07:02:00-04:00,CASI,negative
212609.0,"CASI Pharmaceuticals Names Rong Chen, MD, Ph.D. As Chief Medical Officer",2015-03-04 07:05:00-05:00,CASI,neutral
212610.0,US Stock Futures Signal Lower Start On Wall Street,2015-02-09 07:21:00-05:00,CASI,negative
212611.0,CASI Pharmaceuticals Announces Receipt Of Final Minutes From FDA Meeting Regarding Clinical And Regulatory Path Of ENMD-2076 For The Treatment Of Patients With Fibrolamellar Carcinoma (FLC),2015-02-09 07:06:00-05:00,CASI,neutral
212612.0,"CASI Pharmaceuticals to Initiate Advanced-stage ENMD-2076 Trial for First-line Treatment of FLC for 2015; CASI to Acquire Additional Drug Candidates for Greater China Region, Worldwide for 2015",2015-01-16 07:10:00-05:00,CASI,positive
212613.0,CASI Pharma Reports Q3 Loss of $0.07/Share,2014-11-14 07:02:00-05:00,CASI,negative
212614.0,CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Soft Tissue Sarcoma,2014-11-12 07:02:00-05:00,CASI,positive
212615.0,US Stock Futures Fall Ahead Of Economic Data,2014-09-23 07:16:00-04:00,CASI,neutral
212616.0,"CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors",2014-09-23 07:02:00-04:00,CASI,neutral
212617.0,Spectrum Pharmaceuticals Out-Licenses Rights for Greater China To CASI Pharmaceuticals For Three Of Its Drugs,2014-09-18 07:02:00-04:00,CASI,positive
212618.0,US Stock Futures Signal Lower Start On Wall Street,2014-07-21 07:35:00-04:00,CASI,negative
212619.0,CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China,2014-07-21 07:01:00-04:00,CASI,negative
212620.0,Casi Pharma Announces Orphan Drug Designation For Hepatocellular Carcinoma Treatment,2014-07-07 07:01:00-04:00,CASI,neutral
